As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Dexcom ( (DXCM)) just unveiled an update. On February 26, 2026, Dexcom’s board expanded to twelve members and appointed Rick Osterloh, Google’s Senior Vice President for Platforms & Devices, as an ...

In 2026, consumer wearables do more. They can flag patterns that may point to real health problems, not just a rough wellness trend.

Parkman Healthcare Partners initiated a 200,000-share stake in Masimo during the fourth quarter. The quarter-end position value rose by $26.01 million as a result. Masimo is not among the fund's top ...

People don't buy consumer wearables just to count steps anymore. They want early warnings, useful health signals, and features they can trust.

DelveInsight's Diabetes Care Devices Market Insights report provides the current and forecast market analysis, individual leading diabetes care devices companies' market shares, challenges, diabetes ...

The diabetes care devices market is largely propelled by the increasing global incidence of diabetes, which is influenced by higher obesity rates, sedentary habits, and an aging population.

Galway will host a national gathering of global technology leaders this April as PorterShed marks 10 years of building an ...

Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...

New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren’t on insulin therapy 1, reinforcing the need to broaden ...